Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kingworld Medicines Group Ltd. reported a decrease in revenue and profit for the first half of 2024 compared to the same period in 2023, with revenue down by 4.9% and profits for the period falling by 4.4%. The company’s gross profit margin also saw a reduction of 1.9 percentage points. Despite the declines, the company managed a valuation gain on investment properties and shared profits from a joint venture and an associate.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.